TerrAscend Corp TSND
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSND is a good fit for your portfolio.
News
-
TerrAscend to Host Second Quarter 2024 Earnings Conference Call
-
Cannabis companies to appeal federal commerce clause lawsuit
-
TerrAscend Announces Results of Annual General Meeting
-
TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary
-
TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313
-
Cannabis companies continue federal legalization push despite marijuana's rescheduling
-
Cannabis stocks rise as U.S. moves to reclassify pot as less dangerous
-
TerrAscend Announces May Conference Participation
Trading Information
- Previous Close Price
- CAD 1.86
- Day Range
- CAD 1.85–2.00
- 52-Week Range
- CAD 1.57–3.21
- Bid/Ask
- CAD 1.93 / CAD 2.00
- Market Cap
- CAD 583.01 Mil
- Volume/Avg
- 107,022 / 199,519
Key Statistics
- Price/Earnings (Normalized)
- 10.65
- Price/Sales
- 1.29
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 36
- Website
- https://www.terrascend.com
Comparables
Valuation
|
Metric
|
TSND
|
AMANAT
|
CURA
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.65 | 142.08 | — |
Price/Book Value | 1.87 | 1.05 | 2.98 |
Price/Sales | 1.29 | 3.20 | 2.21 |
Price/Cash Flow | 79.49 | 14.12 | 46.08 |
Price/Earnings
TSND
AMANAT
CURA
Financial Strength
|
Metric
|
TSND
|
AMANAT
|
CURA
|
|---|---|---|---|
Quick Ratio | 0.21 | — | 0.29 |
Current Ratio | 0.49 | — | 0.72 |
Interest Coverage | −0.59 | — | −0.31 |
Quick Ratio
TSND
AMANAT
CURA
Profitability
|
Metric
|
TSND
|
AMANAT
|
CURA
|
|---|---|---|---|
Return on Assets (Normalized) | −4.95% | 3.51% | −5.56% |
Return on Equity (Normalized) | −12.78% | 4.98% | −16.04% |
Return on Invested Capital (Normalized) | −2.45% | — | −5.52% |
Return on Assets
TSND
AMANAT
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hdbmyjpp | Ysxjj | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Fwvszbmv | Xflspzg | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Ybrwzmfz | Rhxzs | $41.4 Bil | |||
| Viatris Inc
VTRS
| Ylfnxbc | Ypjkj | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Wybqdqsdf | Prgg | $13.7 Bil | |||
| Catalent Inc
CTLT
| Xwqgpnbx | Bvdspmh | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Rcxyykyj | Lknb | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Dhpzsbpm | Cpzrv | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Mcsbgjp | Dxrh | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Ttvxdzft | Jvjp | $2.7 Bil |